1. . Verbesserung der inspektionsmoglichkeiten von Vulva Vagina and Portio. [Improvement of inspection facility of vulva, vagina and porto.] Muchner Med Wochenschr 1925: 72:1733–1742.
2. , , , et al. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1886–1869.
3. , , . Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406–1412.
4. , , , , Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance; a two-year prospective study. Am J Obstet Gynecol 2003;188:1401–1405.
5. , , , et al. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1988;91:626–631.
6. , , , et al. Positive predictive rate of colposcopic examination of the cervix uteri: an overview of literature. Gynecol Oncol Surv 1998;53:97–106.
7. , , , et al. An analysis of 84 244 patients from British Columbia cytology–colposcopy program. Gynecol Oncol 2004;92:127–134.
8. . Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383–1392.
9. . Results of a randomized trial on the management of cytology interpretations of low grade squamous intraepithelial lesion. Am J Obstet Gynecol 2003;188:1393–1400.
10. , , . Correlation between colposcopically directed biopsy and cervical loop excision. Gynecol Oncol 1996;60:400–403.
11. , , , . The accuracy of colposcopic grading for detection of high grade cervical intraepithelial neoplasia. J Low Genit Tract Dis 2009;13:137–144.
12. , , , et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004;191:430–434.
13. , , . The quality of community colposcopic practice. Obstet Gynecol 2004;103:545–548.
14. , , . et al. Interobserver variability of colposcopic interpretations and consistency with final histologic results. J Low Genit Tract Dis 2004;8:212–216.
15. , , , et al. Does experience in colposocopy improve identification of high grade abnormalities?Eur J Obstet Gynecol Reprod Biol 2008;141:75–78.
16. , , , et al. Observer agreement on interpreting colposcopic images of CIN. Gynecol Oncol 1995;58:206–209.
17. , , , . Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264–268.
18. , , , et al. Random biopsy after colposcopy-directed biopsy improves the diagnosis of cervical intraepithelial neoplasia grade 2 or worse. J Low Genit Tract Dis 2010;14:346–351.
19. , , , et al. Genital warts and cervical cancer. 4. A colposcopic index for differentiating subclinical papillomaviral infection from cervical intraepithelial neoplasia. Am J Obstet Gynecol 1984;149:815–823.
20. , , , et al. Genital warts and cervical cancer. 5. The tissue basis of colposcopic change. Am J Obstet Gynecol 1984;149:293–303.
21. , . Genital warts and cervical cancer. 7. An improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia. Am J Obstet Gynecol 1985;153:611–618.
22. . Follow-up of an abnormal Pap test and colposcopy. In (ed.) Textbook of Women’s Health. Philadelphia, PA: Lippincott-Raven, 1998, p. 901.
23. , , , et al. Colposcopy: Principles and Practice Textbook and Atlas. Philadelphia, PA: Saunders, 2002.
24. , , . Colposcopy to evaluate abnormal cervical cytology in 2008. Am J Obstet Gynecol 2009;201:472–480.
25. , , , et al. A prospective study to evaluate the correlation between Reid colposcopic index impression and biopsy histology. J Low Genit Tract Dis 2007;11:147–150.
26. , . Interobserver agreement for colposcopy quality control using digitized colposcopic images during ATLS trial. J Low Genit Tract Dis 2005;9:29–35.
27. , . Prediction of cervical histologic results using an abbreviated Reid colposcopic index during ALTS. Am J Obstet Gynecol 2006;194:704–710.
28. Natural History of CIN: a critical review. Int J Gynecol Pathol 1993;12:186–192.
29. , , , et al. From Papanicolaou to Bethesda: the rationale for a new cervical cytology classification. Obstet Gynecol 1991;77:779–782.
30. . Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from randomized trial. JNCI 2000;92:397–402.
31. , , , et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277–284.
32. , . From human papillomavirus to cervical cancer. Obstet Gynecol 2010;116:177–185.
33. . Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol 1996;175:1099–1104.
34. , , , et al. Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533–1536.
35. , , , . Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. JNCI 1996;88:317–318.
36. , , , et al. Cohort study of risk of cervical intraepithelial neoplasia grade 2 or 3 associated with cervical papillomavirus infection. N Engl J Med 1992;327:1272–1278.
37. , , , et al. Can the number of cigarettes smoked predict high-grade cervical intraepithelial neoplasia among women with mildly abnormal cervical smears?Am J Obstet Gynecol 1998;179:399–402.
38. , , , et al. Risk factors for cervical intraepithelial neoplasia: differences between low and high-grade lesions. Am J Epidemiol 1994;140:700–710.
39. , , , et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intraepithelial neoplasia, Int J Cancer 1998;78:281–285.
40. , , , et al. Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand 1998;77:678–682.
41. , , , et al. Risk factors for high-risk type papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev 1999;8:615–620.
42. , , , et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 1989;298:707–710.
43. , , , et al. A population-based study of microinvasive disease of the cervix – a colposcopic and cytologic analysis. Gynecol Oncol 1992;45:9–12.
44. , , . Positive predictive rate of colposcopic examination of the cervix uteri: an overview of literature. Obstet Gynecol Surv 1998;53:97–106.
45. , , , et al. Colposcopic assessment in microinvasive carcinoma of the cervix. Chin Med J 1989;43:171–176.
46. , , , et al. Cervical intraepithelial neoplasia in pregnancy. Int J Gynecol Obstet 1982;20:111–118.
47. , . Management of abnormal Papanicolaou smears in pregnancy. Obstet Gynecol 1979;53:484–488.
48. , , , et al. Cervical carcinoma associated with pregnancy. Obstet Gynecol Surv 1995;50:228–239.
49. , , , et al. Cancer in the pregnant patient. In , , (eds.) Principles and Practice of Gynecologic Oncology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1997, p. 463.
50. , , , et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007: 346–355.
51. , , et al. Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013;121:829–846.
52. , , , et al. Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions diagnosed during pregnancy. Cancer 2004;102:228–232.
53. . The effect of pregnancy on the cervical squamocolumnar junction in patients with abnormal cervical cytology. Am J Obstet Gynecol 1979;134:759–760.
54. , , , et al. Cone biopsy during pregnancy. Obstet Gynecol 1982;60:450–455.
55. , , , et al. Outcome of pregnancy after conization. Acta Obstet Gynecol Scand 1982;61:461–466.
56. , , , et al. Dysplasia during pregnancy: a cytologic follow-up study. J Reprod Med 1981;26:66–72.
57. , , , . Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol 1999;93:359–362.
58. , , , et al. Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions diagnosed during pregnancy. Cancer 2004;102:228–232.
59. , , , et al. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol 1982;59:735–746.
60. , , , et al. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008;197:279–282.
61. , , , et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218–226.
62. , , , et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000;154:127–134.
63. , , , et al. Prevalence of sexually transmitted infections among female adolescents aged 14–19 in the United States. Pediatrics 2009;124:1505–1512.
64. . Impact of HPV infection in adolescent populations. J Adolesc Health 2005;37(Suppl):S3–S9.
65. , , . et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis 2012;16:175–204.
66. , . Colposcopy in special circumstances: Pregnancy, immunocompromise, including HIV and transplants, adolescence and menopause. Best Pract Res Clin Obstet Gynecol 2011;25:653–665.
67. . UNAIDS Report on Global AIDS Epidemic. New York: UNAIDS, 2010.
68. . Management of cervical neoplasia in human immunodeficiency virus infected women. JNCI Monogr 1998;23:43–49.
69. , , , et al. HIV Epidemiology Research Study. Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis 2006;42:855–861.
70. , , , et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343–1349.
71. , , , et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. JNCI 1999;91:226–236.
72. , , , et al. Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women. Eur J Gynaecol Oncol 1995;16:410–417.
73. , . Review of human immunodeficiency virus and squamous lesions of the uterine cervix. Diagn Cytopath 2010;39:65–72.
74. . HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol 2005;19:269–276.
75. , , , et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women’s interagency HIV study. J Acquire Immune Defic Syndr 2001;27:432–442.
76. , , , et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1989;2:570–575.
77. , , , et al. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164:593–599.
78. , , , et al. High risk of human papillomavirus infection and squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1992;165:392–400.
79. , , , et al. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for conditions. AIDS 1992;6:173–178.
80. , , , et al. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994;170:1404–1409.
81. , , , et al. Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis 2007;11:90–97.
82. , , , et al. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338–344.
83. , , , , . Surgical management of cervical intraepithelial neoplasia in HIV-infected women. Eur J Obstet Gynecol Reprod Biol 2008;141:153–157.
84. , , , et al. Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women. Gynecol Oncol 2010;119:92–97.
85. , , , et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986;68:251–258.
86. . Cancers in cyclosporine-treated vs. azathioprine treated patients. Transplant Proc 1996;28:876–878.
87. , , , et al. Increased risk of cervical dysplasia in long term survivors of allogeneic stem cell transplantation- implications for screening and HPV vaccination. Biol Blood Marrow Transplant 2008;14:1072–1095.
88. , ., , et al. Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression?J Clin Rheumatol 2010;16:153–157.
89. , , , et al. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case control study. Gastroenterology 2009;136:451–458.
90. . Treatment of Opportunistic Infections. Washington, DC: US Department of Health and Human Services, National Institutes of Health, CDC, 2006.
91. ., , , et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201–222.
92. , , ., et al. AIDS Malignancy Subcomittee. British HIV Association guidelines for HIV-associated malignancies 2008. HIV Med 2008;9:336–388.
93. , , . Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284–878.
94. , , , et al. Structural anomalies of the cervix and vagina in women enrolled in the diethylstilbestrol adenosis (DESAD) project. Am J Obstet Gynecol 1984;148:59–66.
95. , , , et al. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Low Genit Tract Dis 2013;17(Suppl 1):S28–S35.
96. , , , et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions:background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch of Pathol Lab Med 2012;136:1266–1297.